Cargando…

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax

BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamakawa, Hideaki, Tsukahara, Yuta, Sato, Shintaro, Ohta, Hiroki, Kida, Gen, Nakamura, Tomohiko, Nishizawa, Tomotaka, Kawabe, Rie, Oba, Tomohiro, Akasaka, Keiichi, Amano, Masako, Kuwano, Kazuyoshi, Sasaki, Hiroki, Takemura, Tamiko, Matsushima, Hidekazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787380/
https://www.ncbi.nlm.nih.gov/pubmed/35115749
http://dx.doi.org/10.36141/svdld.v38i4.11465
_version_ 1784639351305535488
author Yamakawa, Hideaki
Tsukahara, Yuta
Sato, Shintaro
Ohta, Hiroki
Kida, Gen
Nakamura, Tomohiko
Nishizawa, Tomotaka
Kawabe, Rie
Oba, Tomohiro
Akasaka, Keiichi
Amano, Masako
Kuwano, Kazuyoshi
Sasaki, Hiroki
Takemura, Tamiko
Matsushima, Hidekazu
author_facet Yamakawa, Hideaki
Tsukahara, Yuta
Sato, Shintaro
Ohta, Hiroki
Kida, Gen
Nakamura, Tomohiko
Nishizawa, Tomotaka
Kawabe, Rie
Oba, Tomohiro
Akasaka, Keiichi
Amano, Masako
Kuwano, Kazuyoshi
Sasaki, Hiroki
Takemura, Tamiko
Matsushima, Hidekazu
author_sort Yamakawa, Hideaki
collection PubMed
description BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothesized that PF-ILD would strongly influence the prognosis of patients with any ILD complicated with SSP. METHODS: We retrospectively surveyed and collected data from patients hospitalized for SSP from January 2016 to June 2020. PF-ILD was defined as the following occurring within 24 months before SSP develops: relative decline in %forced vital capacity (FVC) ≥10% or two of the following: relative decline in %FVC between 5% and 10%, worsening respiratory symptoms, or increased extent of fibrosis on high-resolution computed tomography. RESULTS: We analyzed 32 patients hospitalized for SSP in ILD. This study comprised 18 patients with PF-ILD and 14 patients with non-PF-ILD. PF-ILD patients had lower body mass index (BMI) and %FVC. No significant differences in survival regarding follow-up period from the time of ILD diagnosis and hospitalization for SSP were observed between the PF-ILD and non-PF-ILD patients. Older age and lower BMI were significant predictors of mortality by multivariate Cox regression analysis. ROC analysis showed BMI ≤17.8 kg/m(2) to reliably predict poor prognosis. CONCLUSIONS: Regardless of whether patients have PF-ILD, older age and lower BMI in patients with ILD places them at higher risk of developing SSP, and prognosis is poor if SSP develops. Therefore, clinical management of physique is important to improve the prognosis of ILD patients.
format Online
Article
Text
id pubmed-8787380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-87873802022-02-02 Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax Yamakawa, Hideaki Tsukahara, Yuta Sato, Shintaro Ohta, Hiroki Kida, Gen Nakamura, Tomohiko Nishizawa, Tomotaka Kawabe, Rie Oba, Tomohiro Akasaka, Keiichi Amano, Masako Kuwano, Kazuyoshi Sasaki, Hiroki Takemura, Tamiko Matsushima, Hidekazu Sarcoidosis Vasc Diffuse Lung Dis Original Article: Clinical Research BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothesized that PF-ILD would strongly influence the prognosis of patients with any ILD complicated with SSP. METHODS: We retrospectively surveyed and collected data from patients hospitalized for SSP from January 2016 to June 2020. PF-ILD was defined as the following occurring within 24 months before SSP develops: relative decline in %forced vital capacity (FVC) ≥10% or two of the following: relative decline in %FVC between 5% and 10%, worsening respiratory symptoms, or increased extent of fibrosis on high-resolution computed tomography. RESULTS: We analyzed 32 patients hospitalized for SSP in ILD. This study comprised 18 patients with PF-ILD and 14 patients with non-PF-ILD. PF-ILD patients had lower body mass index (BMI) and %FVC. No significant differences in survival regarding follow-up period from the time of ILD diagnosis and hospitalization for SSP were observed between the PF-ILD and non-PF-ILD patients. Older age and lower BMI were significant predictors of mortality by multivariate Cox regression analysis. ROC analysis showed BMI ≤17.8 kg/m(2) to reliably predict poor prognosis. CONCLUSIONS: Regardless of whether patients have PF-ILD, older age and lower BMI in patients with ILD places them at higher risk of developing SSP, and prognosis is poor if SSP develops. Therefore, clinical management of physique is important to improve the prognosis of ILD patients. Mattioli 1885 2021 2021-12-31 /pmc/articles/PMC8787380/ /pubmed/35115749 http://dx.doi.org/10.36141/svdld.v38i4.11465 Text en Copyright: © 2021 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article: Clinical Research
Yamakawa, Hideaki
Tsukahara, Yuta
Sato, Shintaro
Ohta, Hiroki
Kida, Gen
Nakamura, Tomohiko
Nishizawa, Tomotaka
Kawabe, Rie
Oba, Tomohiro
Akasaka, Keiichi
Amano, Masako
Kuwano, Kazuyoshi
Sasaki, Hiroki
Takemura, Tamiko
Matsushima, Hidekazu
Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
title Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
title_full Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
title_fullStr Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
title_full_unstemmed Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
title_short Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
title_sort impact of progressive fibrosing interstitial lung disease (ild) in ild patients complicated with secondary spontaneous pneumothorax
topic Original Article: Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787380/
https://www.ncbi.nlm.nih.gov/pubmed/35115749
http://dx.doi.org/10.36141/svdld.v38i4.11465
work_keys_str_mv AT yamakawahideaki impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT tsukaharayuta impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT satoshintaro impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT ohtahiroki impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT kidagen impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT nakamuratomohiko impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT nishizawatomotaka impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT kawaberie impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT obatomohiro impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT akasakakeiichi impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT amanomasako impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT kuwanokazuyoshi impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT sasakihiroki impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT takemuratamiko impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax
AT matsushimahidekazu impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax